Skip to main content
رجوع
PRVA logo

Privia Health Group, Inc.

جودة البيانات: 100%
PRVA
NASDAQ Healthcare Medical - Healthcare Information Services
KWD 21.03
▼ KWD 0.49 (-2.28%)
القيمة السوقية: 2.60B
نطاق اليوم
KWD 20.87 KWD 21.24
نطاق 52 أسبوعًا
KWD 18.77 KWD 26.51
حجم التداول
671,126
متوسط 50 يوم / 200 يوم
KWD 22.70 / KWD 22.86
الإغلاق السابق
KWD 21.52

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 113.5 0.3
P/B 0.0 2.9
ROE % 0.0 3.7
Net Margin % 1.1 3.8
Rev Growth 5Y % 21.8 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 31.000 +47.4%
Low: KWD 22.000 High: KWD 36.000
مكرر الربحية المستقبلي
60.8
ربحية السهم المستقبلية
KWD 0.354
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.4 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.947
KWD 0.906 – KWD 0.989
 3.4 B 1
FY2029 KWD 0.790
KWD 0.756 – KWD 0.826
 3.1 B 1
FY2028 KWD 0.645
KWD 0.510 – KWD 0.870
 2.9 B 5

النقاط الرئيسية

Revenue grew 21.75% annually over 5 years — strong growth
Earnings grew 59.33% over the past year
ROE of 0.01% is below average
Debt/Equity of 0.01 — conservative balance sheet
Generating 162.20M in free cash flow
P/E of 113.49 — premium valuation

النمو

Revenue Growth (5Y)
21.75%
Revenue (1Y)22.26%
Earnings (1Y)59.33%
FCF Growth (3Y)41.80%

الجودة

Return on Equity
0.01%
ROIC0.00%
Net Margin1.08%
Op. Margin1.61%

الأمان

Debt / Equity
0.01
Current Ratio1.60
Interest Coverage0.00

التقييم

P/E Ratio
113.49
P/B Ratio0.00
EV/EBITDA-13657.16
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 22.26% Revenue Growth (3Y) 13.16%
Earnings Growth (1Y) 59.33% Earnings Growth (3Y) -0.35%
Revenue Growth (5Y) 21.75% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.12B Net Income (TTM) 22.92M
ROE 0.01% ROA 0.00%
Gross Margin 9.40% Operating Margin 1.61%
Net Margin 1.08% Free Cash Flow (TTM) 162.20M
ROIC 0.00% FCF Growth (3Y) 41.80%
Safety
Debt / Equity 0.01 Current Ratio 1.60
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio 113.49 P/B Ratio 0.00
P/S Ratio 1.23 PEG Ratio 2.17
EV/EBITDA -13657.16 Dividend Yield 0.00%
Market Cap 2.60B Enterprise Value -467.55B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.12B 1.74B 1.66B 1.36B 966.22M
Net Income 22.92M 14.39M 23.08M -8.59M -188.23M
EPS (Diluted) 0.18 0.11 0.19 -0.11 -1.77
Gross Profit 199.52M 176.85M 161.50M 134.78M 63.66M
Operating Income 34.24M 16.98M 20.65M -19.12M -217.44M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.37T 1.14B 999.90M 792.81M 686.37M
Total Liabilities 578.44B 452.34M 392.51M 273.76M 236.19M
Shareholders' Equity 737.22B 635.18M 561.44M 499.09M 426.87M
Total Debt 9.53B 5.59M 8.29M 11.50M 46.50M
Cash & Equivalents 479.69B 491.15M 389.51M 347.99M 320.58M
Current Assets 911.00B 834.82M 700.80M 551.96M 446.68M
Current Liabilities 568.52B 449.15M 386.95M 264.27M 190.46M

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#755 of 1052
34
Custom Deep Value Investing (Seth Klarman)
#822 of 827
2

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026
دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026